Get it on Google Play

Revolution Medicines' daraxonrasib gets positive EU panel opinion

October 15, 2026 9:46 AM EDT Send to a Friend
Revolution Medicines, Inc. (NASDAQ: RVMD) announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login